Emergent BioSolutions (EBS) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 Revenues Above Consensus
Go back to Emergent BioSolutions (EBS) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 Revenues Above Consensus| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 8.32 -0.07 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.39 | 52 Week High | $44.38 | |||
| Open | $8.33 | 52 Week Low | $24.47 | |||
| Day High | $8.47 | P/E | 416.00 | |||
| Day Low | $8.27 | EPS | $0.02 | |||
| Volume | 476,663 | |||||
